Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib plus temozolomide vs temozolomide in metastatic melanoma
2008-004941-27Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in melanoma comparing Veliparib + temozolomide with Placebo + temozolomide (2 arms). Primary endpoint: Progression-free survival. Started Jun 2009; status: completed.
02
Drugs
veliparib
03
Conditions
melanoma
Beyond the preview
Go deeper on 2008-004941-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004941-27.